Pharvaris NV (PHVS)
37.49
-0.25
(-0.66%)
USD |
NASDAQ |
Sep 10, 14:58
Pharvaris Net Income (Quarterly) : -55.63M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.63M |
| March 31, 2026 | -45.86M |
| December 31, 2025 | -54.40M |
| September 30, 2025 | -43.40M |
| June 30, 2025 | -51.55M |
| March 31, 2025 | -48.77M |
| December 31, 2024 | -37.08M |
| September 30, 2024 | -45.82M |
| June 30, 2024 | -32.01M |
| March 31, 2024 | -30.41M |
| December 31, 2023 | -35.22M |
| September 30, 2023 | -25.67M |
| June 30, 2023 | -23.83M |
| March 31, 2023 | -24.28M |
| Date | Value |
|---|---|
| December 31, 2022 | -39.98M |
| September 30, 2022 | -8.545M |
| June 30, 2022 | -13.43M |
| March 31, 2022 | -17.98M |
| December 31, 2021 | |
| September 30, 2021 | -10.73M |
| June 30, 2021 | -18.33M |
| March 31, 2021 | -7.227M |
| December 31, 2020 | -12.59M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -3.829M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Novartis AG | 3.259B |
| BioAge Labs, Inc. | -26.10M |
| AstraZeneca PLC | 3.076B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 55.63M |
| EPS Diluted (Quarterly) | -0.8172 |
| Enterprise Value | 2.286B |
| Earnings Yield | -8.14% |
| Normalized Earnings Yield | -8.138 |